3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Head & Neck
2
Conditions
Lymphoma
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Head and Neck Neoplasms
2
Uterine Cervical Dysplasia
1
Thyroid Nodule
1
Small Cell Lung Carcinoma
1
Precancerous Conditions
1
Pancreatitis, Chronic
1
Pancreatic Cyst
1
Mouth Diseases
1
Lung Neoplasms
1
Gastrointestinal Stromal Tumors
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Biopsy, Fine-Needle
1
Anus Neoplasms
1
Interventions
Cisplatin
141
Radiotherapy
115
Cetuximab
95
Docetaxel
69
Radiotherapy, Intensity-Modulated
55
Carboplatin
47
pembrolizumab
46
Surveys and Questionnaires
46
Paclitaxel
41
Fluorouracil
39
Radiation
29
Blood Specimen Collection
27
Drug Therapy
26
Erlotinib Hydrochloride
23
Nivolumab
21
Surgical Procedures, Operative
17
Standard of Care
16
Magnetic Resonance Spectroscopy
16
Radiosurgery
14
Pemetrexed
14
Gemcitabine
14
Everolimus
13
Celecoxib
13
durvalumab
12
Low-Level Light Therapy
12
Immunohistochemistry
12
Cyclophosphamide
12
Capecitabine
12
Amifostine
12
Chemoradiotherapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Head and Neck Neoplasms
×
Cytological Techniques
×
Clear all
NCT05010369
2025-06-26
DOLPHIN-VIVO
University of Exeter
Phase NA
Terminated
14 enrolled
NCT04162431
2024-06-11
DOLPHIN-VIVO
University of Exeter
Completed
50 enrolled